Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

NCT05298423

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • VA Long Beach Healthcare System ( Site 2831) Long Beach, California, United States
  • VA West Los Angeles Medical Center ( Site 2808) Los Angeles, California, United States
  • Millennium Oncology Research Clinic ( Site 2801) Hollywood, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 2800) Orange City, Florida, United States
View all 160 locations
View Trial Details
Active, not recruiting

A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

NCT07128199

Conditions
Adjuvant, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center - Duarte Duarte, California, United States
  • City of Hope Comprehensive Cancer Center Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Scripps Clinic Torrey Pines La Jolla, California, United States
View all 252 locations
View Trial Details
Active, not recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 26 locations
View Trial Details
Active, not recruiting

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

NCT05555732

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Arizona Oncology Associates, Pc - Nahoa Prescott Valley, Arizona, United States
  • Hoag Memorial Hospital Prebyterian Newport Beach, California, United States
View all 260 locations
View Trial Details
Active, not recruiting

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

NCT05609578

Conditions
Advanced NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Local Institution - 017-936C Fountain Valley, California, United States
  • Local Institution - 017-936 Fountain Valley, California, United States
  • Local Institution - 017-851 Fullerton, California, United States
  • Local Institution - 017-540 San Francisco, California, United States
View all 94 locations
View Trial Details
Active, not recruiting

Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC

NCT06219317

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • CHU Helora Pole Hospitalier Jolimont Haine-Saint-Paul, Belgium
  • CHU Mont Godinne - UCL Namur Yvoir, Belgium
  • CH de La Cote Basque - Saint Leon Bayonne, France
View Trial Details

Related conditions